Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma
Introduction: Treatment of relapsed or refractory acute myeloid leukemia (R/R AML) and myeloid sarcoma (MS) has presented challenges for decades. Studies on selinexor in combination with various standard or intensive chemotherapy regimens for the treatment of R/R AML have demonstrated promising resu...
Saved in:
Main Authors: | Xiwen Tong (Author), Jie Jin (Author), Bin Xu (Author), Shuai Su (Author), Li Li (Author), Mengyuan Li (Author), Yizhou Peng (Author), Xia Mao (Author), Wei Huang (Author), Donghua Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity profile and outcomes of salvage chemotherapy regimens in children and adolescents with relapsed/refractory acute myeloid leukemia
by: Maharshi Trivedi, et al.
Published: (2024) -
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
by: Mariarita Spampinato, et al.
Published: (2024) -
Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
by: Erica Rodrigues de Araujo Vasconcelos, et al.
Published: (2017) -
Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020) -
Initial Presentation of Acute Myeloid Leukemia in a Patient With Cutaneous Myeloid Sarcoma
by: Simant Ankit, et al.
Published: (2019)